Demo data. These are fictitious sample companies used to preview GroWiser. The figures are not real and are not investment information.
Himgiri Pharma Ltd
NSE: HIMGIRIPHBSE: 514760Pharma Formulations
₹2,019.55
▲ 30.30 (+1.52%)
Cash Flow
- FY22: 565
- FY23: 710
- FY24: 620
- FY25: 723
- FY26: 927
- FY22: -315
- FY23: -419
- FY24: -362
- FY25: -527
- FY26: -462
- FY22: -163
- FY23: 202
- FY24: 303
- FY25: -340
- FY26: -85
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operating activity | 565 | 710 | 620 | 723 | 927 |
| Capital expenditure | -315 | -419 | -362 | -527 | -462 |
| Cash from investing activity | -332 | -421 | -369 | -544 | -496 |
| Cash from financing activity | -396 | -88 | 52 | -519 | -517 |
| Net cash flow | -163 | 202 | 303 | -340 | -85 |
Figures in ₹ Cr unless marked per share (₹). Consolidated.
Showing 5 of 10 periods. Premium unlocks the full 10-year history. See Premium